MABION S.A. IR
press release · 2025
Leading european biologics CDMO Mabion, releases first batch of Novalgen’s next-generation T-cell engager, NVG-222 for first in-human clinical trials 17.06.2025 Learn more
press release · 2025
Leading european biologics CDMO Mabion, releases first batch of Novalgen’s next-generation T-cell engager, NVG-222 for first in-human clinical trials 17.06.2025 Learn more
Source document